Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology in Drug Development|September 20, 2018
Pharmacokinetics, Excretion, and Mass Balance of [14 C]-Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy MenClaire Ambery, Graeme Young, Teresa Fuller, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 13, 2023
Population-based evaluation of the effectiveness of nirmatrelvir-ritonavir for reducing hospital admissions and mortality from COVID-19Kevin L Schwartz, Jun Wang, Mina Tadrous, et al.
The Lancet. Infectious Diseases|April 13, 2015
Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trialPeter Daley, Vijayakumar Jagannathan, K R John, et al.
Respiratory Research|July 14, 2018
Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trialGeorge Bardsley, Peter Daley-Yates, Amanda Baines, et al.
Advances in Therapy|June 29, 2023
DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling ApproachDave Singh, Diego Litewka, Rafael Páramo, et al.
Plos One|May 11, 2010
Tuberculosis infection among young nursing trainees in South IndiaDevasahayam J Christopher, Peter Daley, Lois Armstrong, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 24, 2023
The role of modeling studies in asthma management and clinical decision-making: a Delphi survey of physician knowledge and perceptionsThitiwat Sriprasart, Ma Bella Siasoco, Bhumika Aggarwal, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|April 13, 2026
Evaluating equitable access based on sociodemographic predictors of nirmatrelvir-ritonavir use during the first year of availability in Ontario, Canada: A population-based ecological studyMeagan Lacroix, Bradley J Langford, Cynthia Chen, et al.
Plos One|March 9, 2010
Risk factors for MDR and XDR-TB in a tertiary referral hospital in IndiaV Balaji, Peter Daley, Alok Azad Anand, et al.
Contemporary Clinical Trials|April 15, 2026
Lessons learned and recommendations from the Canadian adaptive platform trial of treatments for COVID in community settings (CanTreatCOVID)Benita Hosseini, Amanda Condon, Bruno R da Costa, et al.
Pageof 8